Pharmaceuticals
Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.
Pharmaceuticals
48
results for
Pharmaceuticals
Filters
Refine your search
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20190000639
TDS
Excipient having possible use in pharmaceutical applications.
TDS
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
- It maintains low level of endotoxins with the bioburden limits- BET/MLT
- Controlled metallic impurities
- Developed for…
TDS
Excipient for use in pharmaceutical applications. It acts as a preservative.
TDS
Antioxidant for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
- DMF filed excipient - CDE # F20200000188
- All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
TDS
Excipient developed for pharmaceutical applications. It acts as an antioxidant.
TDS
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
- DMF filed excipient - CDE # F20200000188
- All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
TDS
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
- DMF filed excipient - CDE # F20200000188
- All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
TDS
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS
Excipient designed for pharmaceutical applications. It acts as a stabilizer.
TDS
Antifoam agent for use in oral pharmaceutical preparations such as tablets and soft gel capsules. It
also acts as human and veterinary API to treat gastrointestinal disorders. Shelf life: 48 months.Benefits:
- 100% active
- Kosher & Halal Certified
- Fully USP compliant
- GMP and DMF certified
TDS
Antifoam agent designed for oral pharmaceutical applications
such as soft gel capsules and
tablets. It also acts as human and veterinary API treat gastrointestinal
disorders. Shelf life: 24 months. Benefits:
- Possesses low viscosity
- Kosher & Halal certified
- Fully EP & USP…
TDS
Antifoam agent developed
for pharmaceutical applications like cell culture fermentations. It also
acts as human and veterinary API to treat gastrointestinal disorders. It is
suitable for liquid dosage forms such as syrups and suspensions. Shelf life: 24
months.
Benefits:
- Compatible with aqueous formulations…
TDS